Literature DB >> 25488318

Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.

Nurul Fadilah Mohamad1, Adliah Mhd Ali, Noraida Mohamed Shah.   

Abstract

BACKGROUND: Prescribing medicines in an unlicensed and off-label manner for children is a widespread practice around the world.
OBJECTIVES: To determine the extent and predictors of off-label respiratory drug prescriptions for children in the outpatient clinics of a hospital in Malaysia.
SETTING: Outpatient clinics at the Universiti Kebangsaan Malaysia Medical Centre, a tertiary teaching hospital in Malaysia.
METHODS: The pharmacy-based computer system and medical records of the patients were utilized to collect data from 220 pediatric patients who were prescribed at least one respiratory drug from July 2011 to December 2011. MAIN OUTCOME MEASURE: Characteristics of the off-label respiratory drug prescriptions were measured.
RESULTS: A total of 134 children (60.9 %) received at least one respiratory drug prescribed in an off-label manner. The most common reasons for the off-label prescribing of drugs were off-label use by indication (31.5 %), followed by higher than the recommended dose (24.9 %) and lower than the recommended frequency (17.1 %). Diphenhydramine was the most common respiratory drug prescribed off-label. The number of medications prescribed was the only significant predictor of off-label prescription of respiratory drugs. Pediatric patients receiving 4-6 medications were 7.8 times more likely to receive at least one off-label respiratory drug compared to pediatric patients that received 1-3 medications (OR 7.8, 95 % CI 1.74-37.44).
CONCLUSION: There was substantial prescribing of respiratory drugs for children in an off-label manner at the outpatient clinics at the Universiti Kebangsaan Malaysia Medical Centre. This highlights the need for more research to be carried out on respiratory drugs in the pediatric population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25488318     DOI: 10.1007/s11096-014-0049-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  14 in total

1.  In-label and off-label use of respiratory drugs in the Italian paediatric population.

Authors:  P Baiardi; A Ceci; M Felisi; L Cantarutti; S Girotto; M Sturkenboom; E Baraldi
Journal:  Acta Paediatr       Date:  2010-01-27       Impact factor: 2.299

Review 2.  Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.

Authors:  Jennifer Mason; Munir Pirmohamed; Tony Nunn
Journal:  Eur J Clin Pharmacol       Date:  2011-07-22       Impact factor: 2.953

3.  The newborn drug development initiative.

Authors:  George P Giacoia; Debra L Birenbaum; Hari Cheryl Sachs; Donald R Mattison
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

4.  Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors:  S Turner; A J Nunn; K Fielding; I Choonara
Journal:  Acta Paediatr       Date:  1999-09       Impact factor: 2.299

5.  Unlicensed and off-label prescription of respiratory drugs to children.

Authors:  G W 't Jong; I A Eland; M C J M Sturkenboom; J N van den Anker; B H C Strickerf
Journal:  Eur Respir J       Date:  2004-02       Impact factor: 16.671

6.  Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil.

Authors:  Djanilson Barbosa Santos; Antonio Clavenna; Maurizio Bonati; Helena Lutescia Luna Coelho
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

Review 7.  Respiratory medicines for children: current evidence, unlicensed use and research priorities.

Authors:  A R Smyth; A Barbato; N Beydon; H Bisgaard; K de Boeck; P Brand; A Bush; B Fauroux; J de Jongste; M Korppi; C O'Callaghan; M Pijnenburg; F Ratjen; K Southern; D Spencer; A Thomson; H Vyas; A Warris; P J Merkus
Journal:  Eur Respir J       Date:  2009-10-19       Impact factor: 16.671

8.  Adverse drug reactions and off-label drug use in paediatric outpatients.

Authors:  Benjamin Horen; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

9.  Off-label prescribing to children in the United States outpatient setting.

Authors:  Alicia T F Bazzano; Rita Mangione-Smith; Matthias Schonlau; Marika J Suttorp; Robert H Brook
Journal:  Acad Pediatr       Date:  2009-02-11       Impact factor: 3.107

10.  Off-label prescribing for allergic diseases in children.

Authors:  Diana Silva; Ignacio Ansotegui; Mário Morais-Almeida
Journal:  World Allergy Organ J       Date:  2014-02-14       Impact factor: 4.084

View more
  3 in total

1.  Antihistamines prescribed off-label among paediatric patients at a tertiary care hospital setting in Malaysia.

Authors:  Rou Wei Tan; Noraida Mohamed Shah
Journal:  Int J Clin Pharm       Date:  2016-08-01

2.  Attitudes, knowledge and views on off-label prescribing in children among healthcare professionals in Malaysia.

Authors:  Shamala Balan; Mohamed Azmi Ahmad Hassali; Vivienne S L Mak
Journal:  Int J Clin Pharm       Date:  2019-06-13

Review 3.  Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review.

Authors:  Wasim Shuib; Xin-Yin Wu; Fang Xiao
Journal:  World J Pediatr       Date:  2021-06-02       Impact factor: 2.764

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.